OncoMed Pharmaceuticals Inc Insider Trading for January 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OncoMed Pharmaceuticals Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in OncoMed Pharmaceuticals Inc for January 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 11 2017 | OMED | OncoMed Pharmaceut ... | LASERSOHN JACK W | Director | Sell | J | 0.00 | 108,810 | 0 | 380,299 | 489.1 K to 380.3 K (-22.25 %) |
| Jan 11 2017 | OMED | OncoMed Pharmaceut ... | LASERSOHN JACK W | Director | Sell | J | 0.00 | 305,122 | 0 | 1,119,905 | 1.4 M to 1.1 M (-21.41 %) |
| Jan 11 2017 | OMED | OncoMed Pharmaceut ... | LASERSOHN JACK W | Director | Buy | J | 0.00 | 30,501 | 0 | 107,588 | 77.1 K to 107.6 K (+39.57 %) |
| Jan 09 2017 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Option Exercise | M | 1.43 | 21,369 | 30,558 | 0 | |
| Jan 09 2017 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Option Exercise | M | 1.43 | 21,369 | 30,558 | 21,369 | |
| Jan 09 2017 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Sell | S | 8.52 | 21,369 | 181,957 | 37,323 | 58.7 K to 37.3 K (-36.41 %) |
| Jan 09 2017 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Buy | M | 1.43 | 21,369 | 30,558 | 58,692 | 37.3 K to 58.7 K (+57.25 %) |
| Jan 09 2017 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Sell | S | 8.17 | 21,369 | 174,602 | 37,323 | 58.7 K to 37.3 K (-36.41 %) |
| Jan 09 2017 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Buy | M | 1.43 | 21,369 | 30,558 | 58,692 | 37.3 K to 58.7 K (+57.25 %) |
| Jan 05 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Option Exercise | A | 7.66 | 65,000 | 497,900 | 65,000 | |
| Jan 05 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Option Exercise | M | 1.43 | 9,175 | 13,120 | 0 | |
| Jan 05 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Sell | S | 7.63 | 9,175 | 70,045 | 31,636 | 40.8 K to 31.6 K (-22.48 %) |
| Jan 05 2017 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Buy | M | 1.43 | 9,175 | 13,120 | 40,811 | 31.6 K to 40.8 K (+29.00 %) |
| Jan 05 2017 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | SVP & General Couns ... | Option Exercise | A | 7.66 | 55,000 | 421,300 | 55,000 | |
| Jan 05 2017 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Option Exercise | A | 7.66 | 176,000 | 1,348,160 | 176,000 | |
| Jan 05 2017 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Option Exercise | A | 7.66 | 65,000 | 497,900 | 65,000 | |
| Jan 05 2017 | OMED | OncoMed Pharmaceut ... | Gurney Austin | See Remarks | Option Exercise | A | 7.66 | 55,000 | 421,300 | 55,000 | |
| Jan 05 2017 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology ... | Option Exercise | A | 7.66 | 55,000 | 421,300 | 55,000 | |
| Jan 05 2017 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology ... | Option Exercise | M | 1.43 | 12,763 | 18,251 | 0 | |
| Jan 05 2017 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology ... | Sell | S | 7.64 | 12,763 | 97,448 | 60,979 | 73.7 K to 61 K (-17.31 %) |
| Jan 05 2017 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology ... | Buy | M | 1.43 | 12,763 | 18,251 | 73,742 | 61 K to 73.7 K (+20.93 %) |